Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:36 pm Sale |
2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Ikarian Capital LLC | 1,750,043 5.900% |
-86,502 (-4.71%) |
Filing History |
| 2022-02-14 4:36 pm Sale |
2021-12-31 | 13G | Odonate Therapeutics, Inc. ODTC |
Ikarian Capital LLC | 0 3.500% |
-0 (-32.51%) |
Filing History |
| 2022-02-14 4:35 pm Sale |
2021-12-31 | 13G | scPharmaceuticals Inc. SCPH |
Ikarian Capital LLC | 901,362 3.300% |
-564,785 (-38.52%) |
Filing History |
| 2022-02-14 4:34 pm Unchanged |
2021-12-31 | 13G | Science 37 Holdings, Inc. SNCE |
Ikarian Capital LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-14 4:34 pm Sale |
2021-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Ikarian Capital LLC | 6,628 1.000% |
-20,039 (-75.14%) |
Filing History |
| 2022-02-14 4:32 pm Sale |
2021-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM |
Ikarian Capital LLC | 496,756 5.900% |
-3,244 (-0.65%) |
Filing History |
| 2022-02-14 4:32 pm Sale |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Ikarian Capital LLC | 36,576 0.200% |
-1,027,385 (-96.56%) |
Filing History |
| 2022-02-14 4:31 pm Sale |
2021-12-31 | 13G | Millendo Therapeutics, Inc. MLND |
Ikarian Capital LLC | 58,803 0.900% |
-31,065 (-34.57%) |
Filing History |
| 2022-02-14 4:30 pm Sale |
2021-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Ikarian Capital LLC | 394,536 3.000% |
-420,828 (-51.61%) |
Filing History |
| 2021-09-17 3:00 pm Purchase |
2021-09-16 | 13G | aTyr Pharma, Inc. ATYR |
Ikarian Capital LLC | 888,580 5.300% |
888,580 (New Position) |
Filing History |
| 2021-07-02 4:05 pm Purchase |
2021-06-11 | 13G | Odonate Therapeutics, Inc. ODTC |
Ikarian Capital LLC | 0 5.200% |
0 (New Position) |
Filing History |
| 2021-04-08 09:02 am Purchase |
2021-03-23 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Ikarian Capital LLC | 2,624,988 11.100% |
1,798,564 (+217.63%) |
Filing History |
| 2021-04-07 5:25 pm Purchase |
2021-03-18 | 13G | Millendo Therapeutics, Inc. MLND |
Ikarian Capital LLC | 89,868 7.100% |
89,868 (New Position) |
Filing History |
| 2021-02-16 08:33 am Purchase |
2020-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Ikarian Capital LLC | 135,842 17.800% |
27,715 (+25.63%) |
Filing History |
| 2021-02-16 08:31 am Purchase |
2020-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Ikarian Capital LLC | 1,063,961 5.900% |
117,356 (+12.40%) |
Filing History |
| 2021-02-16 07:49 am Purchase |
2020-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Ikarian Capital LLC | 815,364 6.300% |
30,000 (+3.82%) |
Filing History |
| 2021-02-12 4:35 pm Purchase |
2020-12-31 | 13G | scPharmaceuticals Inc. SCPH |
Ikarian Capital LLC | 1,466,147 5.400% |
392,500 (+36.56%) |
Filing History |
| 2021-02-12 4:32 pm Sale |
2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Ikarian Capital LLC | 1,364,990 3.500% |
-227,449 (-14.28%) |
Filing History |
| 2021-02-12 4:32 pm Sale |
2020-12-31 | 13G | Strongbridge Biopharma plc SBBP |
Ikarian Capital LLC | 2,440,028 3.600% |
-802,759 (-24.76%) |
Filing History |
| 2021-02-12 4:31 pm Purchase |
2020-12-31 | 13G | Yumanity Therapeutics, Inc. YMTX |
Ikarian Capital LLC | 18,931 1.300% |
18,931 (New Position) |
Filing History |